Type 2 Diabetes Trial, Not Yet Recruiting NCT07280780 Sponsor: Korea University Anam Hospital Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07280780
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between the ages of 20 and 60 years.
  • People who are already scheduled to receive a steroid injection into the spine (either in the neck or lower back area) at a pain clinic.
  • People who are able to understand and use a small wearable device that tracks blood sugar levels continuously (called a CGM device).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently taking or using steroid medications in any form.
  • People who have been diagnosed with Type 1 Diabetes.
  • People who have a condition called Cushing's disease, which involves the body producing too much of a stress hormone called cortisol.
  • People who have had a steroid injection into the spine within the past 3 months.
  • People who have a known allergic reaction to contrast dye, which is sometimes used in medical imaging procedures.
  • People who take blood-thinning medications or medicines that help prevent blood clots.
  • People who are not able to understand or use a continuous blood sugar monitoring (CGM) device.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sunmin Kim, M.D., Korea University Anam Hospital

Phone: +82-2-920-5632

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Korea University Anam Hospital
Registry
ClinicalTrials.gov
Start date
20 April 2026
Est. completion
20 December 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Change in Daily Mean Glucose; Change in Time in Range (TIR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov